Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actuate, Aldeyra, Cantargia, Celldex, Ferring, OSE, Redx, Tharimmune, Thetis, Tiziana, Topas.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aptose, Chemomab, Eupraxia, Immutep, Janus, J&J, Nanobiotix, Opus, PTC, Recursion, Regeneration, Spyre, Theralase, Unity.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AN2, Astrazeneca, Transcode.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Design, Tris.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Briacell, Immunic, Napo, Therini, Xencor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agenus, Ankyra, Astrazeneca, Bayer, Cingulate, Coherus, Idorsia, Incyte, Novadip, Palatin , Puma, Relmada.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Alterity, Boehringer, CG Oncology, Chemomab, Immunitybio, J&J, Levicept, Merck, Oncoinvent, Pfizer, Revolution, Senti, Urogen, Yoltech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alx Oncology, Cytoagents, Genentech, Geovax, Neurocrine, Realta, Roche, Vyne.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bioxodes, Inmagene, Insmed, Ipsen, Mineralys, Spyglass.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Ascletis, Braintree, BMS, Cellenkos, Unity.